Literature DB >> 7973437

Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis.

R Olsson1, C Johansson, G Lindstedt, D Mellström.   

Abstract

BACKGROUND: Data on risk factors for bone loss in chronic active hepatitis (CAH) and primary biliary cirrhosis (PBC) are scanty and/or conflicting.
METHODS: Bone mineral density (BMD) in the distal forearm was measured using single-photon absorptiometry in 39 patients with CAH and 32 patients with PBC. We also attempted to identify risk factors for bone loss by means of a questionnaire and through a wide range of biochemical analyses.
RESULTS: In the CAH patients BMD is inversely related to the duration of steroid treatment and to age at menarche. In the PBC patients there was a strong correlation between BMD and serum gastrin concentrations.
CONCLUSIONS: Bone loss in CAH is to some extent explained by steroid treatment and delayed menarche. Bone loss in PBC may be reduced by increased calcitonin secretion induced by gastrocalcin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7973437     DOI: 10.3109/00365529409092505

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Bone mineral densities in individuals with Gilbert's syndrome: a cross-sectional, case-control pilot study.

Authors:  G Y Minuk; R Greenberg; J Uhanova; K Hawkins; W D Leslie
Journal:  Can J Gastroenterol       Date:  2009-06       Impact factor: 3.522

2.  Increased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfection.

Authors:  D D Byrne; C W Newcomb; D M Carbonari; M S Nezamzadeh; K B F Leidl; M Herlim; Y X Yang; S Hennessy; J R Kostman; M B Leonard; A R Localio; V Lo Re
Journal:  J Viral Hepat       Date:  2015-03-06       Impact factor: 3.728

3.  Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection.

Authors:  Ingolf Schiefke; Andreas Fach; Marcus Wiedmann; Andreas-V Aretin; Eva Schenker; Gudrun Borte; Manfred Wiese; Joachim Moessner
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

4.  Chronic non-cholestatic liver disease is not associated with an increased fracture rate in children.

Authors:  Jerzy Konstantynowicz; Dariusz M Lebensztejn; Elzbieta Skiba; Maria E Sobaniec-Lotowska; Pawel Abramowicz; Janina Piotrowska-Jastrzebska; Maciej Kaczmarski
Journal:  J Bone Miner Metab       Date:  2010-09-14       Impact factor: 2.626

5.  Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection.

Authors:  Dana D Byrne; Craig W Newcomb; Dena M Carbonari; Melissa S Nezamzadeh; Kimberly B F Leidl; Maximilian Herlim; Yu-Xiao Yang; Sean Hennessy; Jay R Kostman; Mary B Leonard; A Russell Localio; Vincent Lo Re
Journal:  J Hepatol       Date:  2014-04-05       Impact factor: 25.083

Review 6.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

Review 7.  Current understanding of osteoporosis associated with liver disease.

Authors:  Inaam A Nakchbandi; Schalk W van der Merwe
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11       Impact factor: 46.802

8.  Primary biliary cirrhosis and osteoporosis: a case-control study.

Authors:  Aziza Mounach; Zhor Ouzzif; Ghizlane Wariaghli; Lahsen Achemlal; Imane Benbaghdadi; Aziz Aouragh; Ahmed Bezza; Abdellah El Maghraoui
Journal:  J Bone Miner Metab       Date:  2008-07-04       Impact factor: 2.626

Review 9.  Osteoporosis after solid organ and bone marrow transplantation.

Authors:  Adi Cohen; Elizabeth Shane
Journal:  Osteoporos Int       Date:  2003-08-08       Impact factor: 4.507

Review 10.  Primary biliary cirrhosis.

Authors:  Teru Kumagi; E Jenny Heathcote
Journal:  Orphanet J Rare Dis       Date:  2008-01-23       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.